A female patient with adolescent-onset progressive myoclonus epilepsy carrying a truncating MECP2 mutation
Brain and Development · 2023
DOI: 10.1016/j.braindev.2023.07.006 ↗Kurz gefasst
Fallbericht in der Zeitschrift Brain and Development, 2023. Verfasst von Mari Akiyama und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics (Child Neurology), Okayama University Hospital, Okayama, Japan. Electronic address: makiyama@okayama-u.ac.jp. Hauptthemen laut MEDLINE: Rett Syndrome, Intellectual Disability, Epilepsy, Myoclonic Epilepsies, Progressive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Tottori University.
Abstract (Originalsprache)
BACKGROUND: MECP2 is a well-known causative gene for Rett syndrome but other phenotypes have also been reported. Here, we report a case of a female patient with adolescent-onset progressive myoclonus epilepsy (PME) carrying a novel truncating mutation in the MECP2 gene. CASE REPORT: The patient was a 29-year-old woman with infantile-onset intellectual disability of unspecified cause. She had demonstrated slow but steady development with moderate intellectual disability until the age of 16, when she started having epileptic seizures. Her epilepsy progressed intractably with multiple seizure types accompanied by myoclonus, tremor, and gradual regression. She is currently apathetic and requires extensive assistance in all aspects of life. After an extensive work-up for underlying diseases for PME turned out negative, whole-exome sequencing revealed a de novo 113-bp deletion and 3-bp insertion in MECP2, a variant of NM_004992.4:c.1099_1211delinsGGG, p.(His367Glyfs*32). CONCLUSIONS: The clinical presentation of this case was inconsistent with Rett syndrome, and the rapid regression in the patient's twenties was considered characteristic. Mutations of MECP2 may result in variable neurodevelopmental phenotypes and may also be considered a causative gene for adolescent-onset PME.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics (Child Neurology), Okayama University Hospital, Okayama, Japan. Electronic address: makiyama@okayama-u.ac.jp.
- Department of Pediatrics (Child Neurology), Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Pediatrics (Child Neurology), Okayama University Hospital, Okayama, Japan.
Förderung
- Tottori University
Zitieren
APA
Akiyama, M., Akiyama, T., Saitsu, H., Tokioka, Y., Tsukahara, R., Tsuchiya, H., Shibata, T., & Kobayashi, K. (2023). A female patient with adolescent-onset progressive myoclonus epilepsy carrying a truncating MECP2 mutation. Brain and Development. https://doi.org/10.1016/j.braindev.2023.07.006
Vancouver
Akiyama M, Akiyama T, Saitsu H, Tokioka Y, Tsukahara R, Tsuchiya H, et al. A female patient with adolescent-onset progressive myoclonus epilepsy carrying a truncating MECP2 mutation. Brain and Development. 2023. doi:10.1016/j.braindev.2023.07.006
BibTeX
@article{Akiyama2023,
author = {Akiyama, Mari and Akiyama, Tomoyuki and Saitsu, Hirotomo and Tokioka, Yukie and Tsukahara, Rie and Tsuchiya, Hiroki and Shibata, Takashi and Kobayashi, Katsuhiro},
title = {A female patient with adolescent-onset progressive myoclonus epilepsy carrying a truncating MECP2 mutation},
journal = {Brain and Development},
year = {2023},
doi = {10.1016/j.braindev.2023.07.006}
}
EUVIMED